Skip to main content
  • COOL-AMI: Therapeutic Hypothermia Device Shows High Onset Paroxysmal AFib Rates, Longer Ischemic Times vs. Control

    Analyses of the COOL-AMI pivotal trial for a therapeutic hypothermia device, the ZOLL Proteus Intra Vascular Temperature Management System, reveal longer randomization-to-balloon time and longer total ischemic time for the trial device arm, as well as high rates of new-onset paroxysmal atrial fibrillation.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details